Brief: Scynexis Inc Upon Receipt Of Upfront Payment From GSK, Will Have A Projected Cash Runway Of More Than Two Years
11/05/2023 13:46
May 11 (Reuters) - SCYNEXIS Inc SCYX.O :
* SCYNEXIS INC - UPON RECEIPT OF UPFRONT PAYMENT FROM GSK,
WILL
HAVE A PROJECTED CASH RUNWAY OF MORE THAN TWO YEARS
* SCYNEXIS INC - NET LOSS FOR Q1 2023 WAS $0.71 BASIC LOSS
PER
SHARE
Source text for Eikon: ID:nGNXbqKWk6
Further company coverage: SCYX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scynexis
See all newsBrief: Scynexis Announces Phase 1 Study Results For Scy-770, A Novel, Highly Selective, Oral Direct Ampk Activator For The Treatment Of Autosomal Dominant Polycystic Kidney Disease
Brief: Scynexis Announces Appointment Of Sanjay Subramanian As Chief Financial Officer
Scynexis Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Scynexis Q2 swings to profit on warrant adjustment; advances drug studies
Scynexis Inc Expected To Post A Loss Of 51 Cents A Share: Earnings Preview